European Commission approves Import of Monsanto GMOs

The European Commission has approved the import and processing of Monsanto’s Roundup Ready 2 Xtend soybeans, after debates over glyphosate herbicide’s safety delayed the introduction of genetically modified soybean variety for months.

“Today the Commission authorized three GMOs for food/feed uses (soybean MON 87708 x MON 89788, soybean MON 87705 x MON 89788 and soybean FG 72), all of which have gone through a comprehensive authorization procedure, including a favorable scientific assessment by EFSA,” the European Commission said in a statement Friday.

All of the soybeans have gone through a comprehensive authorization procedure, including a favorable scientific assessment by the European Food Safety Authority (EFSA). The approved seeds include Monsanto’s Roundup Ready 2 Xtend.

Following the Commission’s approval Monsanto’s GMO soybeans are now authorized to be used both to feed animals and in human food, but not for planting in the EU. The authorization is now valid for 10 years but the EU warned that “any products produced from these GMOs will be subject to the EU’s strict labeling and traceability rules.”

Although Roundup Ready 2 Xtend soybeans are tolerant to both glyphosate and dicamba herbicides, the use of dicamba herbicide over the top of Roundup Ready 2 Xtend soybeans remains in the late stage of Environmental Protection Agency (EPA) review and is not currently approved by the EPA.

The soybeans had been approved earlier this year by top importer China. Monsanto now plans to supply 15 million US soy acres to the export needs, the company said in a statement.

“With both the EU and Chinese import approvals and the US Environmental Protection Agency (EPA) in the final stages of review for over-the-top use, Monsanto can now look forward to a full system launch in the United States in 2017 and continues to be in a strong position to supply roughly 15 million U.S. soy acres when the selling season arrives,” the company said.

The new GMO crops – coupled with the dicamba/glyphosate cocktail – make up what Monsanto has dubbed the ‘Roundup Ready Xtend crop system,’ designed to trump super weeds that have evolved along with the company’s glyphosate-based Roundup biocide.

Dicamba was first approved in 1967 and has been linked to high rates of cancer and birth defects in the families of food growers, according to government and other scientific studies. Consumer, health, environmental, and farmer advocates have fiercely opposed the new Xtend system over health and environmental concerns.

Europe is the second largest soybean customer as it relies on soybeans to meet demand for meat and dairy products. The entire block produces less than 1 million tons of soya a year, while importing around 35 million tons, according to the World Wide Fund for Nature.


Articles by: Defend Democracy Press

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]